MoneyTree™ Life Sciences Report

August 2014
  • Print-friendly version
MoneyTree™ Life Sciences Report

At a glance

Biotech soars to record high: Investment in biotechnology was the highest since the start of the MoneyTree data series in 1995. Biotech and medical devices industries both see year-over-year double-digit growth in investments.

Regional funding trends: San Francisco Bay Area, Boston, San Diego Metro, New York Metro, and Great Lakes received the most life sciences venture capital dollars during the second quarter of 2014.

The leader, San Francisco Bay Area, received $866 million, with $632 million allocated for biotechnology and the remaining $234 million going to medical devices. San Francisco Bay Area closed 54 deals during the second quarter of 2014, with an average deal size of $16 million.

Further reading

MoneyTree™ venture capital funding: Biotech deals rising
MoneyTree™ venture capital funding: Falling behind
MoneyTree™ venture capital funding: Biotech boost
MoneyTree™ venture capital funding: Capital crunch